Bmal1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| BMAL1 Protein |
|---|
| Protein Name | Brain and Muscle ARNT-Like 1 |
| Gene | ARNTL |
| UniProt ID | Q9C0B1 |
| PDB Structures | 4H10, 4H11, 5SY5 |
| Molecular Weight | 68 kDa |
| Subcellular Localization | Nucleus (primary) |
| Protein Family | bHLH-PAS transcription factor |
BMAL1 (Brain and Muscle ARNT-Like 1), encoded by the ARNTL gene, is a core circadian transcription factor that partners with CLOCK to drive rhythmic gene expression. BMAL1 is essential for circadian rhythm generation and regulates numerous metabolic and physiological processes.
BMAL1 contains functional domains:
- bHLH Domain: DNA binding to E-box sequences (CACGTG)
- PAS-A Domain: Dimerization with CLOCK
- PAS-B Domain: Regulatory functions, ligand binding
- C-terminal Transactivation Domain: Transcriptional activation
BMAL1 lacks the C-terminal region present in other bHLH-PAS proteins, making it unique in the family.
BMAL1 is the essential partner of CLOCK:
- Heterodimer Formation: BMAL1-CLOCK complex is the functional transcription factor
- E-box Recognition: Binds canonical E-box sequences in clock gene promoters
- Transcriptional Activation: Drives expression of PER1/2, CRY1/2, and output genes
- ROR/REV-ERB Regulation: Activates RORα while being repressed by REV-ERBα
BMAL1 controls metabolic genes:
- Gluconeogenesis: Regulates glucose-6-phosphatase and other enzymes
- Lipid Metabolism: Controls fatty acid oxidation and synthesis genes
- Mitochondrial Function: Regulates mitochondrial biogenesis through PGC-1α
- Amyloid Metabolism: BMAL1 regulates γ-secretase components
- Tau Pathology: Alters tau phosphorylation through kinase regulation
- Circadian Disruption: BMAL1 deficiency in AD brains contributes to sleep disorders
- SIRT1 Interaction: SIRT1 deacetylates BMAL1, linking metabolism to circadian function
- Dopamine Biosynthesis: BMAL1 regulates TH and aromatic amino acid decarboxylase
- Mitochondrial Quality Control: Controls PGC-1α and mitochondrial biogenesis genes
- LRRK2 Connection: LRRK2 mutations may disrupt BMAL1 function
- Metabolic Dysregulation: BMAL1-regulated metabolic genes are affected in ALS
- Circadian Rhythms: Loss of circadian BMAL1 rhythms in ALS models
- SIRT1 Activators: NAD+ boosters may enhance BMAL1 activity
- PGC-1α Modulators: Mitochondrial biogenesis activators
- Chronobiotics: Small molecules targeting BMAL1-CLOCK
- Gene Therapy: Expressing BMAL1 to restore circadian function
- Small Molecule Activators: Development of BMAL1-specific activators
- BMAL1 is essential for circadian rhythms and metabolism - Rudic RD et al. PLoS Biology 2004;2:e377.
- Loss of BMAL1 leads to mitochondrial dysfunction - Kondratov RV et al. Cell 2006;127:89-100.
- BMAL1 regulates γ-secretase in Alzheimer's disease - Wu Y et al. Journal of Neurochemistry 2021;156:782-794.
- NAD+-SIRT1 axis regulates BMAL1 - Asher G et al. Cell 2008;134:317-328.
- Circadian BMAL1 in dopaminergic function - Xu J et al. Frontiers in Neuroscience 2020;14:565.
| Partner |
Interaction Type |
Function |
| CLOCK |
Heterodimer |
DNA binding, transcriptional activation |
| PER1/2 |
Indirect |
Negative feedback |
| CRY1/2 |
Indirect |
Repression |
| SIRT1 |
Protein-protein |
Deacetylation |
| RORα |
Competition |
Transcriptional regulation |
| PGC-1α |
Coactivator |
Mitochondrial biogenesis |
The study of Bmal1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.